Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,201 INR | -0.52% | +3.32% | +5.64% |
Apr. 26 | Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024. | CI |
Feb. 02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Sales 2024 * | 42.01B 503M | Sales 2025 * | 47.09B 564M | Capitalization | 279B 3.34B |
---|---|---|---|---|---|
Net income 2024 * | 8.08B 96.77M | Net income 2025 * | 9.5B 114M | EV / Sales 2024 * | 6.44 x |
Net cash position 2024 * | 7.97B 95.47M | Net cash position 2025 * | 13.8B 165M | EV / Sales 2025 * | 5.62 x |
P/E ratio 2024 * |
34.9
x | P/E ratio 2025 * |
29.4
x | Employees | 7,713 |
Yield 2024 * |
0.92% | Yield 2025 * |
0.76% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | -0.55% | ||
1 week | +3.29% | ||
Current month | -1.36% | ||
1 month | -1.70% | ||
3 months | +4.22% | ||
6 months | +25.43% | ||
Current year | +5.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 98-12-31 | |
Chief Executive Officer | 52 | 95-12-31 | |
Director of Finance/CFO | 59 | 98-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 95-12-31 | |
Chairman | 77 | 79-12-30 | |
Director/Board Member | 78 | 08-10-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +1.54% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 2,201 | -0.52% | 47 500 |
24-04-29 | 2,213 | +0.87% | 225,260 |
24-04-26 | 2,194 | +2.50% | 205,252 |
24-04-25 | 2,140 | +0.29% | 35,470 |
24-04-24 | 2,134 | +0.16% | 69,788 |
Delayed Quote NSE India S.E., April 30, 2024 at 02:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.61% | 3.34B | |
+20.43% | 43.75B | |
+27.47% | 22.06B | |
+13.30% | 14.46B | |
+13.04% | 13.62B | |
+38.30% | 11.61B | |
-9.54% | 6.9B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.32B |
- Stock Market
- Equities
- AJANTPHARM Stock